rare malignant skin diseases. Is characterized by various skin lesions, first in the form of chronic skin rash with intense itching and in later stages in tumor formation.
Disease mushroom mycosis is due to the proliferation and malignant transformation of T-lymphocytes. While not clearly identified the exact causes that trigger the mechanism of the disease. The occurrence of malignant lymph is associated with genetic factors, and presence of chronic viral infections.
According to statistics, the disease occurs in one case 345 thousand of the population. In most cases, mushroom mycosis affects people aged 40-60 years, men more often than women. In recent years, increasingly began to detect the disease in its early stages, in connection with the improvement of diagnosis.
Quite often the beginning of mycosis fungoides hidden flows, having a chronic itchy rash. Primary local lesions of the skin, spreading throughout the body, eventually are transformed into tumors. The development of the disease lead to systemic involvement of lymph nodes and internal organs. Clinical manifestations are expressed in increased temperature, night sweats, sudden weight loss.
Depending on the pattern of the disease, distinguish the following forms of mycosis fungoides typical, erythrodermic and beheaded.
In the most common typical form on the skin, less often on the mucous membranes appear much itchy red spots with scaly or weeping surface. With the development of the disease the spots thicken and transformirovalsya in plaque. Later they move into the tumor.
Erythrodermic form is rare and most often occurs without tumor formation. Characterized by itching and redness of the skin with simultaneous thickening of the affected areas of the skin pattern which is pronounced (the red man).
The disease decapitated form begins immediately with the development of the skin tumors.
Patients mushroom mycosis are subject to dispensary records.
Treatment of patients is carried out in specialized hospitals on the basis of combined use of corticosteroids, antitumor antibiotics and cytostatic agents in combination with x-ray-, photo-, and chemo.